<?xml version="1.0" encoding="UTF-8"?>
<list list-type="order">
 <list-item>
  <p>To evaluate the impact of routine molecular POCT on the clinical management of influenza including: the detection rate of influenza, the adherence to national (PHE) influenza guidelines, the speed and appropriateness of NAI use and the speed and appropriateness of isolation facility use.</p>
 </list-item>
 <list-item>
  <p>To evaluate the impact of routine molecular POCT on measures of clinical effectiveness in adults hospitalised with influenza including: time to clinical stability, time on supplementary oxygen, duration of hospitalisation, adverse events and mortality.</p>
 </list-item>
 <list-item>
  <p>To explore the differences in viral detection between upper and lower respiratory tract samples and the changes in viral load that occur over time in NAI-treated and NAI-untreated patients.</p>
 </list-item>
</list>
